Patents by Inventor Murray J. Towle

Murray J. Towle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8097648
    Abstract: The invention provides methods and compositions for use in treating diseases associated with excessive cellular proliferation, such as cancer.
    Type: Grant
    Filed: November 18, 2005
    Date of Patent: January 17, 2012
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Bruce A. Littlefield, Murray J. Towle, Boris M. Seletsky, Melvin J. Yu, Wanjun Zheng
  • Publication number: 20110172446
    Abstract: The invention provides methods and compositions for use in treating diseases associated with excessive cellular proliferation, such as cancer, and intermediates for the synthesis of such compositions.
    Type: Application
    Filed: August 12, 2010
    Publication date: July 14, 2011
    Inventors: Bruce A. Littlefield, Boris M. Seletsky, Murray J. Towle, Melvin J. Yu, Wanjun Zheng
  • Publication number: 20090104285
    Abstract: The invention provides methods and compositions for use in treating diseases associated with excessive cellular proliferation, such as cancer.
    Type: Application
    Filed: December 22, 2008
    Publication date: April 23, 2009
    Inventors: Bruce A. Littlefield, Murray J. Towle
  • Patent number: 7470720
    Abstract: The invention provides methods and compositions for use in treating diseases associated with excessive cellular proliferation, such as cancer.
    Type: Grant
    Filed: October 16, 2003
    Date of Patent: December 30, 2008
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Bruce A. Littlefield, Murray J. Towle
  • Publication number: 20040198806
    Abstract: The invention provides methods and compositions for use in treating diseases associated with excessive cellular proliferation, such as cancer.
    Type: Application
    Filed: October 16, 2003
    Publication date: October 7, 2004
    Inventors: Bruce A. Littlefield, Murray J. Towle
  • Patent number: 6653341
    Abstract: The invention provides methods and compositions for use in treating diseases associated with excessive cellular proliferation, such as cancer.
    Type: Grant
    Filed: October 16, 2002
    Date of Patent: November 25, 2003
    Assignee: Eisai Co., Ltd.
    Inventors: Bruce A. Littlefield, Murray J. Towle
  • Patent number: 6469182
    Abstract: Novel intermediates of the formula They are used in the preparation of macrocyclic analogs.
    Type: Grant
    Filed: April 26, 2001
    Date of Patent: October 22, 2002
    Assignee: Eisai Co., Ltd.
    Inventors: Bruce A. Littlefield, Monica H. Palme, Boris M. Seletsky, Murray J. Towle, Melvin J. Yu, Wanjun Zheng
  • Patent number: 6365759
    Abstract: Intermediate compounds of the formulas for use in the preparation of macrocyclic analogs.
    Type: Grant
    Filed: October 2, 2000
    Date of Patent: April 2, 2002
    Assignee: Eisai Co., Ltd.
    Inventors: Bruce A. Littlefield, Monica H. Palme, Boris M. Seletsky, Murray J. Towle, Melvin J. Yu, Wanjun Zheng
  • Patent number: 6214865
    Abstract: The invention provides halichondrin analogs having pharmaceutical activity, such as anticancer or antimitotic (mitosis-blocking) activity, and methods of identifying agents that induce a sustained mitotic block in a cell after transient exposure of the cell to the agents.
    Type: Grant
    Filed: June 16, 1999
    Date of Patent: April 10, 2001
    Assignee: Eisai Co., Ltd.
    Inventors: Bruce A. Littlefield, Monica H. Palme, Boris M. Seletsky, Murray J. Towle, Melvin J. Yu, Wanjun Zheng